Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$8.16 - $11.33 $3,272 - $4,543
-401 Reduced 0.36%
110,999 $998,000
Q4 2021

Feb 10, 2022

SELL
$10.38 - $15.2 $280,986 - $411,464
-27,070 Reduced 19.55%
111,400 $1.26 Million
Q3 2021

Nov 10, 2021

SELL
$13.6 - $17.88 $363,800 - $478,290
-26,750 Reduced 16.19%
138,470 $2.02 Million
Q2 2021

Aug 02, 2021

BUY
$16.0 - $20.59 $319,840 - $411,594
19,990 Added 13.76%
165,220 $2.69 Million
Q1 2021

Apr 30, 2021

BUY
$19.16 - $28.09 $350,628 - $514,047
18,300 Added 14.42%
145,230 $2.91 Million
Q4 2020

Feb 10, 2021

BUY
$16.4 - $22.9 $88,067 - $122,972
5,370 Added 4.42%
126,930 $2.61 Million
Q3 2020

Nov 12, 2020

BUY
$14.05 - $18.13 $413,632 - $533,747
29,440 Added 31.96%
121,560 $2.14 Million
Q2 2020

Aug 13, 2020

SELL
$9.41 - $16.94 $21,643 - $38,962
-2,300 Reduced 2.44%
92,120 $1.56 Million
Q1 2020

May 13, 2020

BUY
$6.88 - $19.7 $649,609 - $1.86 Million
94,420 New
94,420 $909,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $146M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Pcj Investment Counsel Ltd. Portfolio

Follow Pcj Investment Counsel Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pcj Investment Counsel Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pcj Investment Counsel Ltd. with notifications on news.